Black Friday: 20% off all orders with code BLACK20.

Palm Beach Vitality

← Back to research

Metabolic

Retatrutide

Triple Agonist (GLP-1 / GIP / Glucagon)

The catalog and checkout are on this site. Free shipping on orders over $250. BLACK20 is 20% off. Research use only.

Amino acid sequence

N-terminus →

01YTyr
02XX
03EGlu
04GGly
05TThr
06FPhe
07TThr
08SSer
09DAsp
10YTyr
11SSer
12IIle
13LLeu
14LLeu
15DAsp
16KLys
17KLys
18AAla
19AAla
20QGln
21AAla
22FPhe
23IIle
24EGlu
25YTyr
26LLeu
27LLeu
28EGlu
29GGly
30GGly
31PPro
32SSer
33SSer
34GGly
35AAla
36PPro
37PPro
38PPro
39SSer
→ C
  • Polar
  • Hydrophobic
  • Acidic
  • Basic
  • Linear
  • 39 residues

Scientific Overview

Retatrutide is an investigational peptide that acts at three receptors (GIP, GLP-1 and glucagon). It is studied in multi-receptor signaling research.

Mechanism focus

Combines incretin receptor agonism with glucagon-receptor activity. Research examines how the three receptor pathways interact.

Research Use Cases

  • Next-generation incretin/glucagon pharmacology
  • GIP/GLP-1/glucagon receptor research
  • Metabolic dysfunction–associated steatotic liver disease (MASLD) studies
  • Comparative multi-agonist receptor profiling

Use-Case Study Notations

  • Case-study notation: retatrutide has been evaluated in phase 2 clinical research; see the primary publications for endpoints and methods.
  • Case-study notation: subsequent analyses explore MASLD and related cardiometabolic comorbidities.
  • Compound remains investigational; cite primary trial publications rather than marketing claims. Research use only.

Selected Studies

  1. 01 Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 TrialPubMed 37366315
  2. 02 Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver diseasePubMed 38858523
  3. 03 Retatrutide—A Game Changer in Obesity PharmacotherapyPubMed 40563436
  4. 04 Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritisPubMed 41090431
  5. 05 The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesityPubMed 40022548

Formats & strengths

Every format and strength currently in the catalog. COA available upon request. Free shipping over $250.

Research Use Only. This page is educational and intended for laboratory research context. Products are not for human consumption and are not intended to diagnose, treat, cure, or prevent any disease.

Request pricingView productsAll products